APA (7th ed.) Citation

Munyentwali, H., Bouachi, K., Audard, V., Remy, P., Lang, P., Mojaat, R., . . . Dahan, K. Y. (2013). Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney international, 83(3), 511-516. https://doi.org/10.1038/ki.2012.444

Chicago Style (17th ed.) Citation

Munyentwali, Helene, et al. "Rituximab Is an Efficient and Safe Treatment in Adults with Steroid-dependent Minimal Change Disease." Kidney International 83, no. 3 (2013): 511-516. https://doi.org/10.1038/ki.2012.444.

MLA (9th ed.) Citation

Munyentwali, Helene, et al. "Rituximab Is an Efficient and Safe Treatment in Adults with Steroid-dependent Minimal Change Disease." Kidney International, vol. 83, no. 3, 2013, pp. 511-516, https://doi.org/10.1038/ki.2012.444.